Compounds > cytarabine

cytarabine and Multiple Myeloma

cytarabine has been researched along with Multiple Myeloma in 110 studies

Research

Studies (110)

TimeframeStudies, this research(%)All Research%
pre-199028 (25.45)18.7374
1990's22 (20.00)18.2507
2000's37 (33.64)29.6817
2010's18 (16.36)24.3611
2020's5 (4.55)2.80

Authors

AuthorsStudies
Hong, CI; MacCoss, M; Matsushita, T; Ross, RJ; Ryu, EK; West, CR1
Chhabra, J; Kumar, R; Narang, R; Pahwa, R1
Bashey, A; Brown, S; Holland, HK; Jackson, KC; Morris, LE; Shegda, N; Solh, M; Solomon, SR; Zhang, X1
Bazarbachi, A; Bou Akl, I; El-Cheikh, J; Ghaoui, N; Karout, L; Khalil, PB; Massoud, R; Matar, M; Zahreddine, A1
Bogucka-Fedorczuk, A; Czyz, A; Kalicińska, E; Laszkowska-Lewko, M; Prajs, I; Rybka, J; Sawicki, M; Szeremet, A; Szymczak, D; Wicherska-Pawłowska, K; Wróbel, T1
Ainley, L; Chavda, SJ; Cheesman, S; Counsell, N; Horder, J; Kyriakou, C; Lee, L; Mehta, A; Newrick, F; Papanikolaou, X; Popat, R; Rabin, N; Sive, J; Wechalekar, A; Yong, K1
Liu, WJ; Lyu, Y; Wang, H; Wang, JH; Wang, WD1
He, GL; He, SZ; Li, J; Xu, DR; Zou, WY1
Chi, HS; Huh, J; Jang, S; Kim, S; Lee, K; Park, CJ; Park, CS; Park, JS; Park, SJ; Suh, C; Yoon, DH1
El Azeeim, HA; El Husseiny, NM; Kasem, N; Mattar, MW1
Cavenagh, J; Ingram, W; Quinn, J; Smith, D; Stevens, J; Yong, K1
Hsieh, CH; Hsieh, PY; Lin, SC; Shueng, PW; Tien, HJ; Wang, LY1
Buck, A; Duell, J; Einsele, H; Knop, S; Maeder, U; Rasche, L; Rosenwald, A; Strifler, S1
Akutsu, M; Furukawa, Y; Hiraoka, N; Kano, Y; Kikuchi, J; Koyama, D; Mori, S; Nakamura, Y; Ueda, T; Uesawa, M; Wada, T; Yamauchi, T1
Abboud, CN; Cashen, AF; DiPersio, JF; Fiala, MA; Fletcher, T; Stockerl-Goldstein, KE; Uy, GL; Vij, R; Wang, TF; Westervelt, P; Wu, N1
Adil, SN; Ali, N; Shaikh, MU1
Abidi, MH; Ayash, L; Bhutani, D; Deol, A; Dyson, G; Jain, T; Kim, S; Lum, LG; Ratanatharathorn, V; Uberti, JP; Veeraputhiran, M1
Fang-Lin, L; Hao, L; Ling-Ling, W; Lu-Qun, W; Ming, H; Xiang-Xin, L; Xue-Liang, C1
Liu, HB; Wang, W1
Hu, WT; Liu, HC; Liu, JW; Wang, TT1
Benchekroun, S; Rachid, M; Tazi, I1
Calliada, F; Castagnola, C; Corso, A; Lazzarino, M; Mangiacavalli, S; Varettoni, M; Zappasodi, P1
Bacon, P; Blijlevens, N; D'Addio, A; Einsele, H; Maertens, J; McCann, S; Niederwieser, D; Quinn, B; Rabitsch, W; Roosaar, A; Ruutu, T; Schouten, H; Schwenkglenks, M; Stone, R; Vorkurka, S1
Arpaci, F; Ataergin, S; Kilic, S; Komurcu, S; Kuzhan, O; Ozet, A; Ozturk, B; Ozturk, M1
Batár, P; Kiss, A; Kovácsné Kovács, E; Rejto, L; Reményi, G; Sípos, T; Szarvas, M; Szász, R; Udvardy, M; Váróczy, L1
Antholine, WE; Batey, RA; Datti, A; Dick, J; Dick, JE; Eberhard, Y; Gronda, M; Hurren, R; McDermott, SP; Schimmer, AD; Venugopal, A; Wang, X; Wood, TE; Wrana, J1
Erikci, AA; Ozturk, A; Sayan, O; Tekgunduz, E1
Barzał, J; Gawroński, K; Młot, B; Oborska, S; Rzepecki, P; Szczylik, C; Waśko-Grabowska, A1
Dong, P; Liu, X; Lv, J; Wang, L; Wang, X; Xiao, Q; Yang, Z; Zhang, H1
Akashi, K; Eto, T; Fujisaki, T; Iwasaki, H; Kamimura, T; Kato, K; Miyamoto, T; Muta, T; Ohno, Y; Takamatsu, Y; Takenaka, K; Teshima, T1
Chmielowska, E; Chwieduk, A; Czerw, T; Giebel, S; Glowala-Kosinka, M; Grosicki, S; Holowiecki, J; Jurczyszyn, A; Kruzel, T; Mitrus, I; Najda, J; Nowara, E; Pasiarski, M; Sadus-Wojciechowska, M; Smagur, A1
Bataille, R; Harousseau, JL; Mahé, B; Milpied, N; Misbahi, R; Moreau, P; Morineau, N; Rapp, MJ; Vigier, M1
García, J; Lahuerta, JJ; Lizasoain, M; Sanz, F1
Fanin, R; Geromin, A; Patriarca, F; Prosdocimo, S; Sperotto, A; Zaja, F1
Björkstrand, B; Gruber, A; Johnsen, HE; Pelliniemi, TT; Rasmussen, T; Remes, K1
de la Fuente, J; Goldman, JM; Hatjiharissi, E; Meletis, J; Rahemtulla, A; Szydlo, R; Terpos, E; Viniou, N; Yataganas, X1
Bordone, J; Garcia, C; Milone, JH; Napal, J; Prates, V1
Ardeshna, KM; Bhattacharya, S; D'Sa, S; Foulkes, B; Goldstone, AH; Ings, SJ; Kyriakou, C; Peggs, KS; Watts, MJ; Williams, CD; Yong, K1
Albiero, E; Castaman, G; Elice, F; Madeo, D; Novella, E; Roberti, S; Rodeghiero, F1
Albarello, A; Ballerini, F; Balocco, M; Canepa, L; Canepa, P; Clavio, M; Garrone, A; Gobbi, M; Michelis, GL; Miglino, M; Pierri, I; Varaldo, R1
Bakshi, A; Bhagwat, R; Biswas, G; Khadwal, A; Narayanan, P; Parikh, P; Sastry, P1
Bauchmüller, K; Engelhardt, M; Finke, J; Haas, PS; Ihorst, G; Kühnemund, A1
Blechschmidt, M; Bornhäuser, M; Ehninger, G; Hänel, M; Hölig, K; Kroschinsky, F; Oelschlaegel, U; Ordemann, R; Platzbecker, U; Poppe-Thiede, K; Schaich, M1
Ishizawa, K1
Huang, Q; Pitman, SD1
Attal, M; Avet-Loiseau, H; Benboubker, L; Berthou, C; Caillot, D; Casassus, P; Chaleteix, C; Dib, M; Dorvaux, V; Doyen, C; Facon, T; Fuzibet, JG; Garban, F; Garderet, L; Grosbois, B; Harousseau, JL; Hulin, C; Jaubert, J; Kolb, B; Lamy, T; Leyvraz, S; Marit, G; Mathiot, C; Michallet, M; Mohty, M; Moreau, P; Traullé, C; Wetterwald, M; Yakoub-Agha, I1
Chen, YB; Fu, WJ; Hou, J; Wang, DX; Xi, H; Yuan, ZG1
Barge, R; Bertsch, U; Blau, I; Bos, GM; Breitkreutz, I; Breitkreuz, I; Croockewit, S; de Weerdt, O; Delforge, M; Duersen, U; Goldschmidt, H; Joosten, P; Lokhorst, HM; Martin, H; Naumann, R; Salwender, HJ; Schaafsma, R; Scheid, C; Schlenzka, J; Schmidt-Wolf, I; Sinnige, H; Sonneveld, P; van der Holt, B; van Marwijk-Kooy, M; van Oers, MH; Vellenga, E; Verhoef, G; Wijermans, P; Wittebol, S; Zweegman, S1
Bacon, P; Blijlevens, N; D'Addio, A; Einsele, H; Maertens, J; McCann, S; Niederwieser, D; Quinn, B; Rabitsch, W; Roosaar, A; Ruutu, T; Schouten, H; Schwenkglenks, M; Stone, R; Vokurka, S1
Alexanian, R; Barlogie, B; Dreicer, R; Kantarjian, H; Plunkett, W1
Fujii, H; Kuzuyama, Y; Maekawa, T; Nakagawa, H; Sonoda, Y1
Barbot, C; Jazwiec, B; Mahon, FX; Reiffers, J; Rice, A; Vanès, I1
Evans, SS; Messenger, JC; Nagourney, RA; Su, YZ; Weisenthal, LM1
Bairey, OS; Sandbank, Y; Shaklai, M1
Koskela, K; Pelliniemi, TT; Remes, K1
Markman, M1
Barnett, MJ; Connors, JM; Klingemann, HG; O'Reilly, SE; Phillips, GL; Reece, DE; Shepherd, JD; Sutherland, HJ1
Bhargava, M; Kumar, R; Raina, V; Sharma, A1
Cremer, F; Döhner, H; Goldschmidt, H; Haas, R; Hunstein, W; Moos, M; Schmohl, D; Schulz, R; Sucker, C1
Dyson, PG; Juttner, CA; Roberts, MM; To, LB; Willson, K1
Mizoguchi, H; Wada, M1
Gieseler, F; Gullis, E; Nuessler, V; Pelka-Fleischer, R; Stötzer, O; Wilmanns, W; Zwierzina, H1
Alcorn, MJ; Cook, G; Farrell, E; Franklin, IM; Marinaki, P; Pearson, C; Sharp, RA; Tansey, PJ1
Chen, PM; Chiou, TJ; Fang, FS; Hsieh, RK; Liu, JH; Tung, SL; Tzeng, CH; Wang, WS; Yen, CC1
Abdulkadyrov, KM; Bessmel'tsev, SS; Rukavitsyn, OA1
Delmer, A; Marie, JP1
Anaissie, E; Ayers, D; Barlogie, B; Cheson, B; Cromer, J; Crowley, J; Desikan, KR; Dhodapkar, D; Epstein, J; Fassas, A; Jagannath, S; Mattox, S; Mehta, J; Munshi, N; Naucke, S; Sawyer, J; Siegel, D; Singhal, S; Spoon, D; Tricot, G; Vesole, D1
Kiss, I; Tomasek, J1
Belt, R; Coon, J; Cord, M; Dix, S; Geller, R; Howard, S1
Amadori, S; Avvisati, G; Caravita, T; Cudillo, L; Del Poeta, G; Fioritoni, G; Leone, G; Majolino, I; Mandelli, F; Martelli, M; Meloni, G; Petrucci, MT; Pulsoni, A; Sica, S; Tabilio, A; Tribalto, M1
Bos, NA; de Wolf, JT; Guikema, JE; Hovenga, S; Klip, H; Smit Sibinga, CT; Smit, JW; Vellenga, E1
Ayala-Sánchez, M; Esparza, MA; García-León, LD; González-Llaven, J; Guevara-Moreno, ME; Montiel-Cervantes, L; Rosas-Cabral, A; Sánchez-Cortés, E; Tripp-Villanueva, F; Vela-Ojeda, J1
Chen, MG; Gastineau, DA; Gertz, MA; Greipp, PR; Inwards, DJ; Lacy, MQ; Litzow, MR; Tefferi, A; Witzig, TE1
Fukuno, K; Moriwaki, H; Oyama, M; Tsurumi, H; Yamada, T1
Bataille, R; Harousseau, JL; Mahé, B; Milpied, N; Moreau, P; Morineau, N; Tang, XW1
Clark, RE; Durham, BH; Flory, AJ; Fraser, WD; Ion, EM; Woodcock, BE1
Inwards, DJ; Lacy, MQ; Markovic, SN; Porrata, LF1
Motta, M; Pelizzari, A; Puoti, M; Rossi, G1
Gallagher, M; Garban, F; Jacob, MC; Jouvin-Marche, E; Marche, PN; Moine, A; Sotto, JJ1
Clark, AD; Cook, G; Douglas, KW; Franklin, IM; McQuaker, IG; Mitchell, LD; Parker, AN; Tansey, PJ1
Fanin, R; Filì, C; Patriarca, F; Prosdocimo, S; Sperotto, A; Zaja, F1
Russell, DH; Russell, SD1
Cohen, HJ; Rundles, RW1
Valeriote, FA1
Mutsukage, A; Nakayama, C; Saneyoshi, M; Takahashi, T1
Bergsagel, DE2
Chura, CM; Maddrey, WC; Roll, FJ; Wands, JR1
Durie, BG; Salmon, SE1
Ascari, E; Danova, M; Giordano, M; Invernizzi, R; Luoni, R; Rastaldi, MP; Riccardi, A; Ucci, G; Zambelli, ML1
Kosaka, M; Miyamoto, Y; Mizuguchi, T; Tamura, K1
Barlogie, B1
Bisson, M; Massias, P; Paule, B; Quillard, J1
Alexanian, R; Barlogie, B; Cabanillas, F; Velasquez, WS1
Ho, AD; Hunstein, W; Trümper, LH; Wulf, G1
Higby, D; Mwangemi, PM1
Keane, WM; Khaleeli, M; Lee, GR1
Demeulenaere, L; Hamers, J; Van Hove, W1
Kemper, B; Rich, A1
Baglioni, C; Liberti, P; Zauderer, M1
Alberts, DS; Golde, DW1
Frei, E; Goldin, A; Schabel, FM1
Parker, AC1
Bodey, GP; Frei, E; Freireich, E; Ho, DH1
Crowther, D1
Carter, SK1
Kidson, C1
Cline, MJ1
Cornwell, GG; McIntyre, OR; Mills, RC1
Cohen, SL; Dodsworth, H; Whitelaw, AG1

Reviews

8 review(s) available for cytarabine and Multiple Myeloma

ArticleYear
Melphalan: Recent insights on synthetic, analytical and medicinal aspects.
    European journal of medicinal chemistry, 2022, Aug-05, Volume: 238

    Topics: Antineoplastic Agents, Alkylating; Drug Resistance, Neoplasm; Humans; Melphalan; Multiple Myeloma; Prodrugs; Structure-Activity Relationship

2022
The VAD Scheme versus Thalidomide plus VAD for Reduction of Vascular Endothelial Growth Factor in Multiple Myeloma: A Meta-Analysis.
    BioMed research international, 2018, Volume: 2018

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Humans; Microvessels; Multiple Myeloma; Thalidomide; Treatment Outcome; Vascular Endothelial Growth Factor A; Vincristine

2018
Granular acute lymphoblastic leukemia: a case report and literature review.
    American journal of hematology, 2007, Volume: 82, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Cytoplasmic Granules; Dexamethasone; Doxorubicin; Female; Humans; Immunophenotyping; Methotrexate; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Treatment Outcome; Vincristine

2007
[Progress in the treatment of multiple myeloma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Interferon-alpha; Melphalan; Multiple Myeloma; Prednisone; Remission Induction; Vincristine

1997
[Update on malignant hematologic diseases].
    Bulletin du cancer, 1998, Volume: 85, Issue:1

    Topics: Antineoplastic Agents; Cytarabine; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Multiple Myeloma

1998
The treatment of plasma cell myeloma.
    British journal of haematology, 1976, Volume: 33, Issue:4

    Topics: Animals; Carmustine; Cytarabine; Doxorubicin; Drug Evaluation, Preclinical; Fluorouracil; Humans; Melphalan; Methotrexate; Mice; Mice, Inbred BALB C; Multiple Myeloma; Myeloma Proteins; Prednisone; Procarbazine; Remission, Spontaneous

1976
An assessment of massive-dose chemotherapy of malignant disease.
    Canadian Medical Association journal, 1971, Jan-09, Volume: 104, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cell Division; Cyclophosphamide; Cytarabine; Female; Fluorouracil; Humans; Leukemia L1210; Leukemia, Lymphoid; Lymphoma; Melphalan; Mercaptopurine; Methotrexate; Mice; Multiple Myeloma; Neoplasms; Nitrogen Mustard Compounds; Prednisone; Pregnancy; Time Factors; Trophoblastic Neoplasms; Vinblastine

1971
An overview of the status of the nitrosoureas in other tumors.
    Cancer chemotherapy reports. Part 3, 1973, Volume: 4, Issue:3

    Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Hydroxyurea; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Melanoma; Melphalan; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Vincristine

1973

Trials

20 trial(s) available for cytarabine and Multiple Myeloma

ArticleYear
High-Dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) Conditioning Before Autologous Transplantation for Patients With Multiple Myeloma.
    Transplantation and cellular therapy, 2022, Volume: 28, Issue:8

    Topics: Bendamustine Hydrochloride; Cytarabine; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Multiple Myeloma; Neoplasm Recurrence, Local; Transplantation, Autologous

2022
Impact of the Conditioning Regimen Dose Intensity Before Autologous Stem Cell Transplantation on the Pulmonary Function Test Abnormalities in Patients With Lymphoma and Multiple Myeloma: Single Center Experience.
    Clinical lymphoma, myeloma & leukemia, 2020, Volume: 20, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Cytarabine; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Podophyllotoxin; Respiratory Function Tests; Retrospective Studies; Survival Rate; Transplantation Conditioning

2020
A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma.
    Bone marrow transplantation, 2014, Volume: 49, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Boronic Acids; Bortezomib; Carmustine; Cytarabine; Female; Follow-Up Studies; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Podophyllotoxin; Pyrazines; Stem Cell Transplantation; Transplantation Conditioning

2014
Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience.
    Transplantation proceedings, 2011, Volume: 43, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Calcium Phosphates; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mouthwashes; Multiple Myeloma; Stomatitis; Transplantation Conditioning; Treatment Outcome; Young Adult

2011
Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers.
    Bone marrow transplantation, 2013, Volume: 48, Issue:7

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Autografts; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neutropenia; Platelet Transfusion; Time Factors

2013
Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-study.
    European journal of haematology, 2003, Volume: 70, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Clone Cells; Cytarabine; Dexamethasone; Feasibility Studies; Female; Humans; Male; Middle Aged; Multiple Myeloma; Neoplastic Cells, Circulating; Remission Induction; Vidarabine; Vincristine

2003
Effect of DCEP mobilizing regimen in in vivo purging of PBSC harvests in multiple myeloma.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Leukapheresis; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vincristine

2004
Trial of amifostine in autologous stem cell transplant.
    Bone marrow transplantation, 2006, Volume: 37, Issue:1

    Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Cytarabine; Female; Graft Survival; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Podophyllotoxin; Radiation-Protective Agents; Stem Cell Transplantation; Transplantation, Homologous

2006
Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
    Transfusion, 2006, Volume: 46, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Polyethylene Glycols; Recombinant Proteins; Remission Induction; Transplantation, Autologous; Treatment Outcome

2006
[Efficacy of thalidomide combined dexamethasone on newly diagnosed multiple myeloma].
    Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Constipation; Cytarabine; Dexamethasone; Disease-Free Survival; Fatigue; Follow-Up Studies; Humans; Leukopenia; Middle Aged; Multiple Myeloma; Remission Induction; Survival Rate; Thalidomide; Thrombocytopenia; Vincristine

2007
Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.
    Haematologica, 2008, Volume: 93, Issue:1

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Male; Medical Oncology; Middle Aged; Multiple Myeloma; Remission Induction; Thalidomide; Thioguanine; Treatment Outcome; Vincristine

2008
Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.
    Bone marrow transplantation, 1993, Volume: 11, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Female; Humans; Life Tables; Male; Melphalan; Middle Aged; Multiple Myeloma; Survival Analysis; Transplantation, Autologous; Vincristine

1993
Peripheral blood stem cells mobilized from patients with acute myeloid leukaemia have different platelet repopulating abilities compared with those mobilized from patients with other diseases.
    Bone marrow transplantation, 1996, Volume: 18, Issue:1

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Marrow; Cell Differentiation; Cell Lineage; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Megakaryocytes; Multiple Myeloma; Ovarian Neoplasms; Platelet Count; Thioguanine; Time Factors

1996
Peripheral blood progenitor cell mobilisation in patients with multiple myeloma following oral idarubicin and dexamethasone (Z-Dex) induction therapy.
    Leukemia, 1997, Volume: 11 Suppl 5

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Female; Flow Cytometry; Hematopoietic Stem Cell Mobilization; Humans; Idarubicin; Male; Mesna; Middle Aged; Multiple Myeloma; Remission Induction

1997
Navoban (tropisetron, ICS 205-930) and dexamethasone combination in the prevention of vomiting for patients receiving preconditioning high-dose chemotherapy before marrow transplantation.
    Japanese journal of clinical oncology, 1998, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Carmustine; Child; Cyclophosphamide; Cytarabine; Dexamethasone; Dizziness; Drug Therapy, Combination; Female; Headache; Heartburn; Humans; Indoles; Leukemia; Male; Melphalan; Middle Aged; Multiple Myeloma; Podophyllotoxin; Transplantation Conditioning; Tropisetron; Vomiting; Whole-Body Irradiation

1998
Total therapy with tandem transplants for newly diagnosed multiple myeloma.
    Blood, 1999, Jan-01, Volume: 93, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Middle Aged; Multiple Myeloma; Prognosis; Remission Induction; Treatment Outcome; Vincristine

1999
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study.
    Haematologica, 2000, Volume: 85, Issue:1

    Topics: Adult; Age Factors; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Erythrocyte Transfusion; Evaluation Studies as Topic; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Infections; Italy; Male; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Neutrophils; Platelet Count; Prognosis; Retrospective Studies; Risk Factors; Stem Cells; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine

2000
Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization.
    Bone marrow transplantation, 2000, Volume: 25, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cryopreservation; Cyclophosphamide; Cytarabine; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Prospective Studies; Recombinant Proteins; Regression Analysis; Survival Rate; Transplantation, Autologous

2000
Lack of benefit of CD34+ cell selected over non-selected peripheral blood stem cell transplantation in multiple myeloma: results of a single center study.
    Leukemia, 2000, Volume: 14, Issue:10

    Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Costs and Cost Analysis; Cytarabine; Dexamethasone; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multiple Myeloma; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Vincristine

2000
Dose escalation therapy in previously untreated patients with multiple myeloma following Z-Dex induction treatment.
    British journal of haematology, 2002, Volume: 117, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Interferon alpha-2; Interferon-alpha; Male; Melphalan; Middle Aged; Multiple Myeloma; Recombinant Proteins; Survival Rate; Treatment Outcome

2002

Other Studies

82 other study(ies) available for cytarabine and Multiple Myeloma

ArticleYear
Phospholipid-nucleoside conjugates. 3. Syntheses and preliminary biological evaluation of 1-beta-D-arabinofuranosylcytosine 5'-monophosphate-L-1,2-dipalmitin and selected 1-beta-D-arabinofuranosylcytosine 5-diphosphate-L-1,2-diacylglycerols.
    Journal of medicinal chemistry, 1982, Volume: 25, Issue:11

    Topics: Animals; Antineoplastic Agents; Arabinonucleotides; Cell Division; Chemical Phenomena; Chemistry, Physical; Cytarabine; Diglycerides; Glycerides; Leukemia L1210; Mice; Multiple Myeloma; Neoplasms, Experimental

1982
Higher efficacy of intermediate dose cytarabine + G-CSF compared to cyclophosphamide + G-CSF in hematopoietic stem cell mobilization in patients with multiple myeloma.
    Journal of clinical apheresis, 2020, Volume: 35, Issue:4

    Topics: Adult; Aged; Antigens, CD34; Blood Component Removal; Cyclophosphamide; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Remission Induction; Retrospective Studies; Transplantation, Autologous; Treatment Outcome

2020
DT-PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation.
    British journal of haematology, 2021, Volume: 192, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Progression-Free Survival; Salvage Therapy; Stem Cell Transplantation; Thalidomide; Transplantation, Autologous; Young Adult

2021
[Efficacy and safety of DVD and VAD regimens in patients with newly diagnosed multiple myeloma].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2017, Jun-14, Volume: 38, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Humans; Multiple Myeloma; Vincristine

2017
Remobilization of hematopoietic stem cells with high-dose methotrexate and cytarabine in patients with non-Hodgkin's lymphoma and multiple myeloma after failure to mobilize with chemotherapy and cytokines.
    Transfusion, 2014, Volume: 54, Issue:3

    Topics: Adult; Antigens, CD34; Blood Component Removal; Cytarabine; Cytokines; Female; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Retrospective Studies

2014
Multiple myeloma: a descriptive study of 217 Egyptian patients.
    Annals of hematology, 2014, Volume: 93, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cyclophosphamide; Cytarabine; Dexamethasone; Egypt; Female; Hospitals, Urban; Humans; Kaplan-Meier Estimate; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Pyrazines; Retrospective Studies; Severity of Illness Index; Thalidomide; Vincristine

2014
Myeloma presenting during pregnancy.
    Hematological oncology, 2014, Volume: 32, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cesarean Section; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypercalcemia; Idarubicin; Infant, Newborn; Lenalidomide; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Myeloma Proteins; Osteolysis; Plasmacytoma; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrazines; Remission Induction; Spinal Cord Compression; Thalidomide; Thoracic Vertebrae; Transplantation, Autologous

2014
Total marrow irradiation as part of autologous stem cell transplantation for Asian patients with multiple myeloma.
    BioMed research international, 2013, Volume: 2013

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Radiation; Stem Cell Transplantation; Transplantation, Autologous; Vincristine

2013
The lymphoma-like polychemotherapy regimen "Dexa-BEAM" in advanced and extramedullary multiple myeloma.
    Annals of hematology, 2014, Volume: 93, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Registries; Retrospective Studies

2014
Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignancies.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclophosphamide; Cytarabine; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Inhibitory Concentration 50; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Multiple Myeloma; Pyrimidines; Rituximab

2014
Autologous Hematopoietic Stem Cell Transplantation-10 Years of Data From a Developing Country.
    Stem cells translational medicine, 2015, Volume: 4, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Multiple Myeloma; Transplantation Conditioning; Transplantation, Autologous

2015
BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma.
    Clinical lymphoma, myeloma & leukemia, 2015, Volume: 15, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous

2015
A case of simultaneous occurrence of acute myeloid leukemia and multiple myeloma.
    BMC cancer, 2015, Oct-16, Volume: 15

    Topics: Aclarubicin; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Multiple Myeloma; Remission Induction

2015
[Efficacy Comparison of Low dose Thalidomide Combined with Modified VCMP and VAD regimens for Treatment of Aged MM Patients].
    Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Humans; Melphalan; Multiple Myeloma; Prednisone; Remission Induction; Survival Rate; Thalidomide; Thrombocytopenia; Vincristine

2016
[Expression of Blimp-1 mRNA in Bone Marrow Mononuclear Cells in Multiple Myeloma Patients and Its Clinical Significance].
    Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Cells; Bortezomib; C-Reactive Protein; Cytarabine; Dexamethasone; Flow Cytometry; Humans; Multiple Myeloma; Myeloma Proteins; Plasma Cells; Positive Regulatory Domain I-Binding Factor 1; Real-Time Polymerase Chain Reaction; Repressor Proteins; RNA, Messenger; Vincristine

2016
Sjögren's syndrome associated with multiple myeloma.
    Singapore medical journal, 2008, Volume: 49, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Autoimmunity; Blood Protein Disorders; Blood Sedimentation; Cytarabine; Dexamethasone; Diphosphonates; Female; Humans; Middle Aged; Multiple Myeloma; Remission Induction; Sjogren's Syndrome; Treatment Outcome; Vincristine

2008
Infiltration of the spinal cord in a patient with multiple myeloma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-01, Volume: 26, Issue:25

    Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cytarabine; Dexamethasone; Disease Progression; Fatal Outcome; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Neoplasm Metastasis; Pyrazines; Spinal Cord Neoplasms

2008
The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
    Bone marrow transplantation, 2009, Volume: 43, Issue:2

    Topics: Adult; Aged; Analgesics, Opioid; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Humans; Length of Stay; Lymphoma, Non-Hodgkin; Male; Medical Audit; Melphalan; Middle Aged; Multiple Myeloma; Prospective Studies; Risk Factors; Stem Cell Transplantation; Stomatitis; Transplantation Conditioning

2009
Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2009, Volume: 17, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mucositis; Multiple Myeloma; Neoplasms; Severity of Illness Index; Whole-Body Irradiation; Young Adult

2009
[One hundred fifty autologous peripheral haemopoietic stem cell transplantations and their lessons].
    Orvosi hetilap, 2009, Jul-05, Volume: 150, Issue:27

    Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hungary; International Cooperation; Kaplan-Meier Estimate; Leiomyosarcoma; Lymphoma, Non-Hodgkin; Melphalan; Multiple Myeloma; Nitrosourea Compounds; Time Factors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome

2009
Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.
    Blood, 2009, Oct-01, Volume: 114, Issue:14

    Topics: Animals; Antifungal Agents; Antimetabolites, Antineoplastic; Apoptosis; Cells, Cultured; Ciclopirox; Cytarabine; Drug Synergism; Electron Spin Resonance Spectroscopy; Fibroblasts; Humans; Immunoblotting; Inhibitor of Apoptosis Proteins; Iron; Iron Chelating Agents; Leukemia, Myeloid, Acute; Luciferases; Lung; Mice; Mice, Inbred NOD; Mice, SCID; Microtubule-Associated Proteins; Multiple Myeloma; Promoter Regions, Genetic; Pyridones; Ribonucleotide Reductases; Survivin

2009
Acute myeloid leukemia complicating multiple myeloma: a case successfully treated with etoposide, thioguanine, and cytarabine.
    Clinical lymphoma & myeloma, 2009, Volume: 9, Issue:4

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Subcutaneous; Leukemia, Myeloid, Acute; Multiple Myeloma; Remission Induction; Thioguanine

2009
Fucoidan prevents multiple myeloma cell escape from chemotherapy-induced drug cytotoxicity.
    Fitoterapia, 2013, Volume: 84

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cytarabine; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Multiple Myeloma; Polysaccharides; Time Factors

2013
Evaluation of the feasibility and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:1

    Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Chi-Square Distribution; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Feasibility Studies; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multiple Myeloma; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine

2013
Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma.
    Leukemia, 2002, Volume: 16, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Male; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Prednisone; Survival Rate; Time Factors; Transplantation, Autologous; Vincristine

2002
[Bacteremia due to Capnocytophaga spp.: two cases].
    Enfermedades infecciosas y microbiologia clinica, 2003, Volume: 21, Issue:3

    Topics: 4-Quinolones; Aged; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Capnocytophaga; Carmustine; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Multiple Myeloma; Podophyllotoxin; Transplantation Conditioning

2003
Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients.
    Haematologica, 2003, Volume: 88, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Stem Cell Transplantation; Thalidomide; Vincristine

2003
Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    International journal of cancer, 2003, Sep-01, Volume: 106, Issue:3

    Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Biomarkers; Biomarkers, Tumor; Bone Neoplasms; C-Reactive Protein; Cytarabine; Dexamethasone; Diphosphonates; Female; Glycoproteins; Humans; Interleukin-6; Isoenzymes; Male; Middle Aged; Multiple Myeloma; Osteocalcin; Osteoclasts; Osteogenesis; Osteoprotegerin; Pamidronate; Paraproteins; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reference Values; Sensitivity and Specificity; Tartrate-Resistant Acid Phosphatase; Vincristine

2003
Response to single-agent thalidomide and eligibility to undergo autotransplant for patients with multiple myeloma refractory to VAD.
    Bone marrow transplantation, 2003, Volume: 32, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multiple Myeloma; Patient Selection; Salvage Therapy; Thalidomide; Transplantation, Autologous; Treatment Outcome; Vincristine

2003
Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects.
    British journal of haematology, 2004, Volume: 125, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Plasma Cells

2004
Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.
    Oncology reports, 2005, Volume: 14, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mitoxantrone; Multiple Myeloma; Odds Ratio; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Recurrence; Remission Induction; Salvage Therapy; Time Factors; Transplantation Conditioning; Treatment Outcome

2005
Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period.
    Annals of hematology, 2006, Volume: 85, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Remission Induction; Retrospective Studies; Transplantation, Autologous

2006
[The standard treatments for patients with hematological malignancies in Japan].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:5

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Multiple Myeloma; Prednisone; Rituximab; Survival Rate; Vincristine

2007
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials.
    Leukemia, 2007, Volume: 21, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 4; Cytarabine; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Genetic Heterogeneity; Hemoglobins; Humans; Male; Middle Aged; Multiple Myeloma; Multivariate Analysis; Prognosis; Retrospective Studies; Translocation, Genetic; Vincristine

2007
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Mar-20, Volume: 26, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Europe; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Medical Audit; Melphalan; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Prospective Studies; Research Design; Risk Assessment; Risk Factors; Stomatitis; Transplantation Conditioning; Transplantation, Autologous

2008
High-dose cytosine arabinoside in multiple myeloma.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:2

    Topics: Aged; Arabinofuranosylcytosine Triphosphate; Blood Cell Count; Bone Marrow; Bone Marrow Diseases; Cell Count; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Interphase; Male; Middle Aged; Multiple Myeloma

1984
[Peripheral blood stem cell transplantation in adult patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:4

    Topics: Adolescent; Adult; Blood Cell Count; Cell Separation; Chemotherapy, Adjuvant; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1993
Quality and functional capacity of the bone marrow microenvironment of autologous blood stem cell transplantation (ABSCT) recipients.
    Nouvelle revue francaise d'hematologie, 1994, Volume: 36, Issue:4

    Topics: Bone Marrow; Carmustine; Cells, Cultured; Colony-Forming Units Assay; Connective Tissue; Cyclophosphamide; Cytarabine; Etoposide; Graft Survival; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Multiple Myeloma; Transplantation, Autologous; Whole-Body Irradiation

1994
2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms.
    British journal of cancer, 1993, Volume: 67, Issue:1

    Topics: Cladribine; Cytarabine; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Multiple Myeloma; Protein Binding; Tumor Cells, Cultured; Vincristine

1993
Relapse of aggressive myeloma after complete remission in secondary acute leukemia: coincidence or consequence?
    Leukemia & lymphoma, 1993, Volume: 12, Issue:1-2

    Topics: Antigens, CD; Bone Marrow; Cytarabine; Female; HLA-DR Antigens; Humans; Leukemia, Myelomonocytic, Acute; Melphalan; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Recurrence

1993
VAD regimen in the treatment of resistant multiple myeloma: slow or fast infusion?
    Leukemia & lymphoma, 1993, Volume: 10, Issue:4-5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Female; Humans; Life Tables; Male; Middle Aged; Multiple Myeloma; Neutropenia; Peripheral Nervous System Diseases; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine

1993
Report from the 34th annual meeting of the American Society of Hematology, December 4-8, 1992.
    Journal of cancer research and clinical oncology, 1993, Volume: 119, Issue:11

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon-alpha; Leukemia; Lymphoma, Non-Hodgkin; Medical Oncology; Multiple Myeloma; Societies, Medical

1993
Whole blood harvested after granulocyte-colony stimulating factor (Neupogen) mobilization, and reinfused unprocessed after high-dose melphalan treatment, accelerates hematopoietic recovery in patients with multiple myeloma.
    Cancer, 1996, Mar-15, Volume: 77, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion, Autologous; Cytarabine; Dexamethasone; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Leukocyte Count; Male; Melphalan; Middle Aged; Multiple Myeloma; Pilot Projects; Recombinant Proteins; Vincristine

1996
Detection of minimal residual disease by polymerase chain reaction in B cell malignancies.
    Stem cells (Dayton, Ohio), 1995, Volume: 13 Suppl 3

    Topics: Acute Disease; Base Sequence; Burkitt Lymphoma; Cytarabine; Dose-Response Relationship, Immunologic; Gene Rearrangement; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Molecular Sequence Data; Multiple Myeloma; Neoplasm, Residual; Polymerase Chain Reaction; Transcription, Genetic

1995
Functional P-gp expression in multiple myeloma patients at primary diagnosis and relapse or progressive disease.
    Leukemia, 1997, Volume: 11 Suppl 5

    Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bence Jones Protein; beta 2-Microglobulin; C-Reactive Protein; Cytarabine; Dexamethasone; Disease Progression; Disease-Free Survival; Humans; Immunoglobulin G; Immunoglobulin M; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prognosis; Recurrence; Survival Rate; Vincristine

1997
[The efficacy of polychemotherapy programs in treating multiple myeloma patients].
    Terapevticheskii arkhiv, 1998, Volume: 70, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Remission Induction; Vincristine

1998
Sodium and potassium excretion changes and bone marrow recovery after chemotherapy.
    Stem cells (Dayton, Ohio), 1999, Volume: 17, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Multiple Myeloma; Potassium; Sodium

1999
Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
    Bone marrow transplantation, 1999, Volume: 24, Issue:5

    Topics: Adult; Ambulatory Care; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Diphenhydramine; Etoposide; Evaluation Studies as Topic; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Infusion Pumps; Infusions, Intravenous; Lorazepam; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Nausea; Patient Acceptance of Health Care; Prospective Studies; Safety; Self Care; Thiotepa; Vomiting

1999
Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation.
    Bone marrow transplantation, 2000, Volume: 25, Issue:7

    Topics: Adjuvants, Immunologic; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lenograstim; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Recombinant Proteins; Time Factors; Transplantation, Autologous; Vincristine

2000
Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma.
    Bone marrow transplantation, 2000, Volume: 26, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Female; Graft Survival; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Male; Middle Aged; Multiple Myeloma; Recurrence; Retrospective Studies; Survival Rate; Time Factors; Transplantation, Autologous; Vincristine

2000
[Complete remission of plasmablastic IgD lambda multiple myeloma induced by continuous infusion of low-dose cytarabine and etoposide].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2000, Volume: 41, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Infusions, Intravenous; Male; Multiple Myeloma; Remission Induction; Treatment Outcome

2000
Biochemical markers of bone turnover following high-dose chemotherapy and autografting in multiple myeloma.
    Blood, 2000, Oct-15, Volume: 96, Issue:8

    Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Remodeling; Bone Resorption; Carmustine; Clodronic Acid; Combined Modality Therapy; Cytarabine; Disease Progression; Female; Hematopoietic Stem Cell Transplantation; Humans; Isoenzymes; Male; Melphalan; Middle Aged; Multiple Myeloma; Osteoclasts; Peptide Fragments; Podophyllotoxin; Procollagen; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome

2000
Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
    Bone marrow transplantation, 2001, Volume: 28, Issue:7

    Topics: Adjuvants, Immunologic; Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cells, Cultured; Cytarabine; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Interferon-alpha; Interleukin-2; K562 Cells; Killer Cells, Natural; Lymphocyte Count; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Multiple Myeloma; Podophyllotoxin; Time Factors; Transplantation Conditioning; Transplantation, Autologous

2001
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
    British journal of haematology, 2001, Volume: 115, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hodgkin Disease; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Prednisone; Vidarabine; Vincristine; Virus Activation

2001
Immunotherapy by non-myeloablative stem cell transplantation: study of the immune reconstitution. Arguments for distinct cell subsets in skin and blood.
    The hematology journal : the official journal of the European Haematology Association, 2000, Volume: 1, Issue:4

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Blood; Blood Cells; Carmustine; CD8-Positive T-Lymphocytes; Clone Cells; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Female; Graft Survival; Graft vs Host Reaction; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Immunotherapy; Leukemia, Myeloid; Male; Middle Aged; Minisatellite Repeats; Multiple Myeloma; Prednisone; Receptors, Antigen, T-Cell, alpha-beta; Skin; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Homologous; Vincristine; Whole-Body Irradiation

2000
Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma.
    Haematologica, 2002, Volume: 87, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Humans; Multiple Myeloma; Prognosis; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Time Factors; Transplantation, Autologous; Treatment Outcome; Vincristine

2002
Relative usefulness of measuring polyamines in serum, plasma, and urine as biochemical markers of cancer.
    Clinical chemistry, 1975, Volume: 21, Issue:7

    Topics: Bleomycin; Cadaverine; Chromatography, Ion Exchange; Cytarabine; Diamines; Humans; Multiple Myeloma; Plasma; Prednisone; Putrescine; Spermidine; Spermine; Teratoma; Vinblastine; Vincristine

1975
Managing the complications of plasma cell myeloma.
    Archives of internal medicine, 1975, Volume: 135, Issue:1

    Topics: Acute Kidney Injury; Bacterial Infections; Blood Urea Nitrogen; Blood Viscosity; Bone Neoplasms; Cephalothin; Cyclophosphamide; Cytarabine; Female; Fluoxymesterone; Furosemide; Gentamicins; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Melphalan; Middle Aged; Multiple Myeloma; Neurologic Manifestations; Plicamycin; Renal Dialysis

1975
The use of cell kinetics in the development of drug combinations.
    Pharmacology & therapeutics, 1979, Volume: 4, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Division; Cell Separation; Cell Survival; Cytarabine; DNA, Neoplasm; Drug Administration Schedule; Drug Therapy, Combination; Humans; Kinetics; Leukemia; Models, Biological; Multiple Myeloma; Neoplasms

1979
Inhibition of mouse myeloma DNA polymerase alpha by 5-triphosphates of 1-beta-D-arabinofuranosylthymine and 1-beta-D-arabinofuranosylcytosine.
    Journal of biochemistry, 1978, Volume: 83, Issue:5

    Topics: Animals; Cells, Cultured; Cytarabine; DNA Polymerase II; DNA, Neoplasm; Liver; Mice; Multiple Myeloma; Nucleic Acid Synthesis Inhibitors; Structure-Activity Relationship; Thymine Nucleotides

1978
Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders.
    Gastroenterology, 1975, Volume: 68, Issue:1

    Topics: Adolescent; Adult; Antibodies, Viral; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Daunorubicin; Hepatitis B Antigens; Humans; Leukemia, Lymphoid; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myeloproliferative Disorders; Prednisone; Procarbazine; Vincristine

1975
Cellular kinetics in multiple myeloma. A new approach to staging and treatment.
    Archives of internal medicine, 1975, Volume: 135, Issue:1

    Topics: Azathioprine; Bone and Bones; Bone Neoplasms; Cell Count; Computers; Cytarabine; Diagnosis, Computer-Assisted; Doxorubicin; Humans; Hydroxyurea; Immunoglobulin G; Information Systems; Kinetics; Medical Records; Multiple Myeloma; Myeloma Proteins; Prognosis; Vincristine

1975
[p170 in multiple myeloma and acute leukemia].
    Haematologica, 1991, Volume: 76 Suppl 3

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Colonic Neoplasms; Cytarabine; Daunorubicin; Drug Resistance; Female; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Male; Melphalan; Membrane Glycoproteins; Middle Aged; Multiple Myeloma; Neoplasm Proteins; Neoplastic Stem Cells; Peptichemio; Plasma Cells; Prednisone; Remission Induction; Survival Rate; Tumor Cells, Cultured; Vincristine

1991
[Kinetics of circulating hematopoietic stem cells following chemotherapy in patients with hematopoietic malignancies].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1990, Volume: 31, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Colony-Stimulating Factors; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Vincristine

1990
Diagnosis and treatment of high-grade myeloma.
    The American journal of medicine, 1990, Volume: 88, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Humans; L-Lactate Dehydrogenase; Multiple Myeloma

1990
[Heterogenicity of the response to chemotherapy in plasmablastic myeloma].
    Nouvelle revue francaise d'hematologie, 1987, Volume: 29, Issue:6

    Topics: Adult; Aged; Antigens, Differentiation; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Neprilysin; Prednisolone; Prednisone; Prognosis; Vincristine

1987
Etoposide, dexamethasone, cytarabine, and cisplatin in vincristine, doxorubicin, and dexamethasone-refractory myeloma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance; Etoposide; Humans; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Vincristine

1989
Addition of verapamil to overcome drug resistance in multiple myeloma: preliminary clinical observations in 10 patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Drug Resistance; Female; Humans; Male; Middle Aged; Multiple Myeloma; Verapamil; Vincristine

1989
Cytosine arabinoside, cyclophosphamide and total body irradiation conditioning regimens for bone marrow transplantation.
    East African medical journal, 1985, Volume: 62, Issue:5

    Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Infant; Leukemia; Male; Middle Aged; Multiple Myeloma; Whole-Body Irradiation

1985
Sideroblastic anemia in multiple myeloma: a preleukemic change.
    Blood, 1973, Volume: 41, Issue:1

    Topics: Anemia, Sideroblastic; Bone Marrow Examination; Cytarabine; Female; Humans; Immunodiffusion; Immunoelectrophoresis; Immunoglobulins; Iron; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Melphalan; Mercaptopurine; Middle Aged; Multiple Myeloma; Muramidase; Precancerous Conditions; Prednisone; Staining and Labeling; Vincristine

1973
Acute leukaemia in myeloma.
    Lancet (London, England), 1973, Sep-08, Volume: 2, Issue:7828

    Topics: Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Male; Melphalan; Mercaptopurine; Middle Aged; Multiple Myeloma

1973
Identification of presumptive histone messenger RNA in rapidly labelled polysomal RNA of mouse myelomas.
    Biochimica et biophysica acta, 1973, Sep-07, Volume: 319, Issue:3

    Topics: Animals; Centrifugation, Density Gradient; Cytarabine; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Female; Histones; Isotope Labeling; Mice; Mice, Inbred BALB C; Multiple Myeloma; Neoplasms, Experimental; Plasmacytoma; Polyribosomes; RNA, Messenger; RNA, Ribosomal; Spectrophotometry, Ultraviolet; Time Factors; Tritium; Uridine

1973
Distribution of histone messenger RNA among free and membrane-associated polyribosomes of a mouse myeloma cell line.
    Journal of molecular biology, 1973, Sep-25, Volume: 79, Issue:3

    Topics: Animals; Binding Sites; Cell Fractionation; Cell Line; Cell Membrane; Centrifugation, Density Gradient; Cytarabine; Dactinomycin; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Histones; Immunoglobulins; Mice; Multiple Myeloma; Osmolar Concentration; Polyribosomes; Potassium Chloride; RNA, Messenger; RNA, Ribosomal; Spectrophotometry, Ultraviolet

1973
DNA synthesis in multiple myeloma cells following cell cycle-nonspecific chemotherapy.
    Cancer research, 1974, Volume: 34, Issue:11

    Topics: Alkylating Agents; Autoradiography; Bone Marrow; Bone Marrow Cells; Cell Division; Cells, Cultured; Cytarabine; DNA Repair; DNA, Neoplasm; Humans; Hydroxyurea; Multiple Myeloma; Remission, Spontaneous; Thymidine; Tritium

1974
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Cancer research, 1974, Volume: 34, Issue:1

    Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Models, Animal; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Hodgkin Disease; Humans; Leukemia; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Mechlorethamine; Melphalan; Mice; Mice, Inbred AKR; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Remission, Spontaneous; Vinblastine; Vincristine

1974
A case of acute myelomonocytic leukaemia associated with myelomatosis.
    Scandinavian journal of haematology, 1973, Volume: 11, Issue:4

    Topics: Aged; Autopsy; Blood Cell Count; Blood Protein Disorders; Blood Protein Electrophoresis; Bone Marrow; Bone Marrow Cells; Cytarabine; Daunorubicin; Humans; Immunoelectrophoresis; Immunoglobulin G; Leukemia, Myeloid; Male; Melphalan; Multiple Myeloma; Prednisone

1973
Pharmacologic and cytokinetic studies of arabinosyl cytosine.
    Bibliotheca haematologica, 1973, Volume: 39

    Topics: Adolescent; Adult; Animals; Antibody Formation; Cell Migration Inhibition; Child; Child, Preschool; Cyclophosphamide; Cytarabine; DNA; DNA Nucleotidyltransferases; Drug Therapy, Combination; Humans; Leukemia, Experimental; Leukemia, Myeloid, Acute; Lymphocyte Activation; Macrophages; Mice; Mitosis; Multiple Myeloma; Prednisone; Vincristine

1973
Blood and neoplastic diseases. Rational approach to the chemotherapy of human malignant disease-II.
    British medical journal, 1974, Oct-26, Volume: 4, Issue:5938

    Topics: Antineoplastic Agents; Brain Neoplasms; Busulfan; Cell Count; Cell Division; Cytarabine; Diffusion; Drug Tolerance; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocyte Count; Lymphoma; Methotrexate; Multiple Myeloma; Neoplasms; Vincristine

1974
Analysis of DNA fine secondary structure in relation to replication and transcription.
    Cold Spring Harbor symposia on quantitative biology, 1968, Volume: 33

    Topics: Amino Acids; Bacillus subtilis; Carbon Isotopes; Chromatography; Countercurrent Distribution; Culture Media; Cytarabine; Dactinomycin; DNA Replication; DNA, Bacterial; DNA, Neoplasm; Escherichia coli; Genetic Code; Genetics, Microbial; Multiple Myeloma; Tritium

1968
Prediction of in vivo cytotoxicity of chemotherapeutic agents by their effect on malignant leukocytes in vitro.
    Blood, 1967, Volume: 30, Issue:2

    Topics: Blood Cell Count; Cytarabine; DNA; Humans; In Vitro Techniques; Injections, Intravenous; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Mercaptopurine; Multiple Myeloma; Prednisone; RNA; Tritium; Uridine; Vincristine

1967
Remission of leukemia associated with multiple myeloma.
    The New England journal of medicine, 1971, Oct-14, Volume: 285, Issue:16

    Topics: Cytarabine; Humans; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Multiple Myeloma; Remission, Spontaneous

1971
Leukaemia on myeloma.
    British medical journal, 1971, Nov-20, Volume: 4, Issue:5785

    Topics: Adult; Bronchopneumonia; Cytarabine; Humans; Leukemia, Myeloid, Acute; Male; Melphalan; Multiple Myeloma; Plasmacytoma; Thioguanine

1971